USE OF ALPHA 1-ANTICHYMOTRYPSIN POLYPEPTIDES, OR NUCLEIC ACIDS ENCODING THEM, IN COMBINATION WITH ALPHA 1-ANTITRYPSIN POLYPEPTIDES, OR NUCLEIC ACIDS ENCODING THEM, FOR TREATMENT AND/OR PREVENTION OF DIABETES-ASSOCIATED AND/OR ARTERIAL POORLY HEALING WOUNDS

The invention relates to a use of alpha 1-antichymotrypsin (ACT) polypeptides, functional variants thereof and/or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide or a nucleic acid encoding it in combination with alpha-1-antitrypsin (AAT) polypeptides, functional vari...

Full description

Saved in:
Bibliographic Details
Main Authors GOPPELT, ANDREAS, HALLE, JOERN-PETER
Format Patent
LanguageEnglish
French
Published 13.05.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a use of alpha 1-antichymotrypsin (ACT) polypeptides, functional variants thereof and/or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide or a nucleic acid encoding it in combination with alpha-1-antitrypsin (AAT) polypeptides, functional variants thereof or nucleic acids encoding them, or of a cell which is expressing an AAT polypeptide, or a nucleic acid encoding it. L'invention concerne l'utilisation de polypeptides d'alpha 1-antichymotrypsine (ACT), de variants fonctionnels de ceux-ci ou d'acides nucléiques codant pour ceux-ci, ou d'une cellule exprimant un polypeptide d'ACT ou un acide nucléique qui code pour ce dernier, en combinaison avec des polypeptides d'alpha 1-antitrypsine (AAT), des variants fonctionnels de ceux-ci ou des acides nucléiques codant pour ceux-ci, ou avec une cellule qui exprime un polypeptide d'AAT ou un acide nucléique codant pour ce dernier.
Bibliography:Application Number: WO2003EP11856